Nebenwirkungen · Levemir
Levemir Penfill 100 units/ml solution for injection in cartridge. Levemir FlexPen 100 units/ml solution for injection in pre-filled pen. Levemir InnoLet 100 units/ml solution for injection in pre-filled pen. Levemir FlexTouch 100 units/ml solution for injection in pre-filled pen. · Abschnitt 4.8 · PDF-Seite 7
HOS-112636 · Präparat HOS-093711
The most frequently reported adverse reaction during treatment is hypoglycaemia, please see section 4.8, Description of selected adverse reactions. From clinical investigations, it is known that major hypoglycaemia, defined as requirement for third party intervention, occurs in approximately 6% of the patients treated with Levemir.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2021-07-13T14:43:00Z · SHA-256 f2dce42e61ebc94b66c4ed9218db75538c2d50223fdd9ddd163a69c26e372423 · Passage 64b03e31b03a825f9a1e89f4efb7043f2db2473843a64fd69c0ac0ca9282362e · Zeichen 248–581 im Abschnitt